• UCLA Health
  • myUCLAhealth
  • School of Medicine
Institute of Urologic Oncology

UCLA Institute of Urologic Oncology

Institute of Urologic Oncology
  • About Us
    • Director's Welcome
    • Board of Directors
    • IUO in the News
    • Why Choose the UCLA IUO
    • Support the IUO
    • Contact Us
    • The Wasserman Building
    • Maps and Directions
    • IUO Membership Information
    • Administrative & Research Staff
    • Positions Available
  • Clinical Programs
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
    • Testicular Cancer
    • Integrated Cancer Program
    • Cancer Genetic Risk Assessment Program
    • Second Opinion for Cancer
  • Research Programs
    • Clinical Trials
    • Faculty Labs
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
    • LuPSMA Risk Calculator
    • PSMA Risk Calculator
    • SPORE In Prostate Cancer
    • Webinars / Videos
  • Clinical Trials
    • What Is a Clinical Trial?
    • Who Should Consider Clinical Trials & Why
    • Bladder Cancer Clinical Trials
    • Kidney Cancer Clinical Trials
    • Prostate Cancer Clinical Trials
    • Testicular Cancer Clinical Trials
    • Clinical Research Team
    • IUO Membership Study Information
  • For Patients
    • Contact Us
    • Clinical Updates
    • Maps and Directions
    • myUCLAhealth
    • Webinars / Videos
  • Fellowship
    • Current Fellows
    • Former Fellows
    • Fellow Testimonials
    • UCLA Health Aerial Tour
    • Webinars/Videos
  • For Healthcare Professionals
    • How to Refer a Patient
    • Lectures & Conferences
    • CTSI Distinguished Speaker Seminar Series
    • DGSOM Research Seminars
    • DGSOM Events
    • JCCC Seminars
    • Researcher Resources
    • SPORE Lectures
  • Expert Team
    • Board of Directors
    • Medical Oncology
    • Nuclear Medicine
    • Pathology
    • Radiation Oncology
    • Radiology
    • Urologic Oncology
    • Research Faculty
    • Emeritus Faculty
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Institute of Urologic Oncology

Clinical Trials

Clinical Trials

Clinical Trials

  • What Is a Clinical Trial?
  • Who Should Consider Clinical Trials & Why
  • Bladder Cancer Clinical Trials
  • Kidney Cancer Clinical Trials
  • Prostate Cancer Clinical Trials
  • Testicular Cancer Clinical Trials
  • Clinical Research Team
  • IUO Membership Study Information
  • What Is a Clinical Trial?
  • Who Should Consider Clinical Trials & Why
  • Bladder Cancer Clinical Trials
  • Kidney Cancer Clinical Trials
  • Prostate Cancer Clinical Trials
  • Testicular Cancer Clinical Trials
  • Clinical Research Team
  • IUO Membership Study Information
  1. Home
  2. Institute of Urologic Oncology
  3. Clinical Trials
  4. GU Cancer Repository

GU Cancer Repository

Share this

Lay Title: GU Cancer Repository for Genitourinary Cancers

Technical Title: Data and Specimen Repository for Individuals with/at Risk for Genitourinary Cancers

Disease Type:
Patients with recently diagnosed genitourinary cancers (prostate, bladder, renal, testicular, adrenal, or penile cancers) and benign conditions such as renal cysts (fluid filled sacs in the kidney).

Basic information:
The purpose of this study is to construct a biologic specimen bank for research purposes.

This biologic specimen bank will study the genetic and biological factors contributing to the development of genitourinary cancers (prostate, bladder, renal, testicular, adrenal, or penile cancers) and benign conditions such as renal cysts (fluid filled sacs in the kidney). In the future, these specimens will be used for research on the study of cancer and benign conditions. Scientists will study the genes and the proteins that are found both in cancer and in normal tissue in hope it leads to improved clinical care in the future.

Research Procedures (not a complete list):
A portion of the material removed from patient’s body during standard clinical care will be retrieved, such as bodily fluids, blood, and tissue. Material requested can vary based on the type of material and the specific condition. The specimens will be stored in the biobank. In the future, these specimens will be used for research on the study of cancer and benign conditions in hope it would lead to improved clinical care.

Eligibility Criteria (Not a complete list):

Inclusion Criteria:

  • Patients with a high risk of developing or currently having a diagnosis of a genitourinary cancer (such as prostate, bladder, renal, testicular, adrenal, or penile cancers)

Exclusion Criteria:

  • Under 18 years old
  • Unwilling or unable to provide informed consent

For More Detailed Information, Contact:

  • Brian Shuch, MD, Principal Investigator
  • Shirin Zavoshi, MD, (310) 794-9493
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest